Source-grounded facts extracted from vTv Therapeutics Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Rudy Howard resigned as Chief Financial Officer at vTv Therapeutics Inc..
“On December 1, 2021, (the “Effective Date”) Rudy Howard announced his resignation as Chief Financial Officer and as an employee of vTv Therapeutics Inc. (the “Company”), effective as of the Effective Date.”
Deepa Prasad was appointed as Director at vTv Therapeutics Inc..
“On the Effective Date, the Company announced that the Board has appointed Deepa Prasad as President and Chief Executive Officer and as a member of the Board.”
Deepa Prasad was appointed as President and Chief Executive Officer at vTv Therapeutics Inc..
“On the Effective Date, the Company announced that the Board has appointed Deepa Prasad as President and Chief Executive Officer and as a member of the Board.”
Stephen Holcombe retired as Chief Executive Officer at vTv Therapeutics Inc..
“On October 19, 2021, (the “Effective Date”) Stephen Holcombe announced his retirement as Chief Executive Officer and as an employee of vTv Therapeutics Inc. (the “Company”), effective as of the Effective Date.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.